• A
• B
• C
• D
• E
• F
• G
• H
• I
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

Ataluren (Translarna®)

Atezolizumab (Tecentriq® ) for Urothelial Carcinoma 2L

Atezolizumab (Tecentriq®)

Atezolizumab (Tecentriq®) for triple-negative breast cancer.

Atezolizumab (Tecentriq®) in combination with carboplatin and etoposide for 1L ES-SCLC HTA ID: 19030

Avanafil (Spedra®)

Avelumab (Bavencio®)

Avelumab (Bavencio®) in combination with axitinib (Inlyta®) for first line treatment of metastatic renal cell carcinoma. HTA ID: 19046

Axicabtagene Ciloleucel (Yescarta®)

Axitinib (Inlyta®)